Testing effectiveness (Phase 2)Ended earlyNCT00290706
What this trial is testing
A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
Who this might be right for
Lymphoma
Northwestern University 32